Oxford Asset Management’s Biote Corp BTMD Stock Holding History

Oxford Asset Management’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,536	Closed	-$158K	–	501
2024 Q4	$158K	Buy	+25,536	New	+$148K	0.07%	364

Other funds holding BTMD

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oxford Asset Management's BTMD Position: Q1 2025 in Review

Oxford Asset Management sold out of Biote Corp (BTMD) in Q1 2025, closing a stake of 25,536 shares — an estimated $158K sold.

Oxford Asset Management first reported a position in BTMD in Q4 2024 and held it in 1 quarter. The position peaked at $158K in Q4 2024. 90 funds tracked by Wall St. Rank hold BTMD as of Q1 2025.

Oxford Asset Management reported no remaining Biote Corp position as of Q1 2025 after selling out during the quarter.
Oxford Asset Management sold 25,536 Biote Corp shares in Q1 2025, an estimated $158K.
Oxford Asset Management first reported a position in Biote Corp in Q4 2024 and held it in 1 quarter.
Oxford Asset Management's Biote Corp position peaked at $158K in Q4 2024.
90 funds tracked by Wall St. Rank held Biote Corp as of Q1 2025.

Based on Oxford Asset Management's 13F filing for Q1 2025, filed 15 May 2025.